Clinical trial Recruiting at 4 sites Interventional Ages 18 and up

Endo-SPONGE treatment for lower pelvic anastomotic or Hartmann's stump leakages

Official title: A Prospective Multicenter Trial Evaluating the Safety and Effectiveness of Endo-SPONGE for the Treatment of Anastomotic or Hartmann's Stump Leakages in the Lower Pelvic Area

Run by Boston Scientific Corporation · NCT07035431 · Data updated 2026-11-12

This study will test whether Endo-SPONGE endoscopic vacuum therapy can safely help close anastomotic or Hartmann's stump leakages in adults after colorectal surgery.

More Anastomotic Leaks trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment66 (estimated)
SponsorBoston Scientific Corporation
Industry-sponsored
Locations10 sites (Sacramento, California and 9 other locations)
StatusRecruiting
StartedNovember 2, 2026
Main results expectedDecember 2028
Study endsDecember 2028
Registry record updatedNovember 6, 2026
Trial IDNCT07035431 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with a confirmed grade B anastomotic or Hartmann's stump leak in the extraperitoneal lower pelvis, a transmural defect ≥2 cm, an existing or newly created diverting ostomy, and who are eligible for endoscopic intervention.

Probably not a fit

Patients under 18, pregnant or otherwise vulnerable individuals, those with leaks outside the extraperitoneal lower pelvis, defects smaller than 2 cm, or who are not candidates for endoscopic therapy are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multicenter interventional study using sponge-based endoscopic vacuum therapy (Endo-SPONGE) to treat anastomotic or Hartmann's stump leakages in the lower pelvic area. Adults with confirmed grade B leaks, an extraperitoneal transmural defect of at least 2 cm, and a diverting ostomy are eligible and will undergo endoscopic placement of the sponge with serial exchanges until defect closure. The study will collect safety data and effectiveness outcomes such as leak closure rate, time to closure, and procedure-related adverse events. Procedures are performed at participating US centers with protocol-defined follow-up visits to document healing and complications.

Why it matters

Potential benefit: If successful, this approach could provide a less invasive option to close pelvic anastomotic or stump leaks, potentially avoiding additional major surgery and shortening recovery.

How similar studies have gone: Previous case series and cohort studies of endoscopic vacuum therapy and Endo-SPONGE have reported promising healing rates and safety, but randomized and large multicenter data remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Confirmed grade B anastomotic leak as per the ISGRC (International Study Group of Rectal Cancer) grading system after colorectal surgery.
* Subject is eligible for endoscopic intervention.
* Subject has a transmural defect of at least 2 cm in diameter following colorectal surgery in the lower pelvic area.
* Subject has an anastomotic or Hartmann's stump leak located within an extraperitoneal cavity.
* Subject has pre-existing diverting ostomy or an ostomy created prior to the first Endo-SPONGE placement.
* Subject understands the trial requirements and is willing and able to comply with the study procedures, all protocol-required follow up evaluations and provide written informed consent to participate in the study.
* Investigator decision that EVT is the most suitable treatment of the available treatment options.

Exclusion Criteria:

* Subject is under 18 years of age.
* Potentially vulnerable subject, including, but not limited to pregnant women.
* Subject has undergone EVT or other similar interventions for the current colorectal indication.
* Subject had colorectal surgery more than 60 days prior to the planned study procedure.
* Subject has any necrotic tissue that would require endoscopic debridement prior to Endo-SPONGE placement.
* Subject has known contraindication for EVT as per the IB.
* Subject is currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor.

Where it's running

  • Mount Sinai
    New York, New York, United States
    Recruiting
  • Penn State Health
    Hershey, Pennsylvania, United States
    Recruiting
  • University of Washington Medical Center
    Seattle, Washington, United States
    Recruiting
  • Marshall University Medical Center
    Huntington, West Virginia, United States
    Recruiting
  • University of California, Davis Medical Center
    Sacramento, California, United States
    Not yet recruiting
  • Orlando Regional Medical Center
    Orlando, Florida, United States
    Not yet recruiting
Show 4 more locations
  • Cleveland Clinic Florida
    Weston, Florida, United States
    Not yet recruiting
  • Lahey Medical Center
    Burlington, Massachusetts, United States
    Not yet recruiting
  • Cleveland Clinic Foundation
    Cleveland, Ohio, United States
    Not yet recruiting
  • Thomas Jefferson University Hospital
    Philadelphia, Pennsylvania, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.